Current ResearchStudies
Healthy volunteers are always needed!
Do you have a Nexplanon® implant?
The purpose of this clinical trial is to learn about using the etonogestrel implant for more than 3 years.
You may be able to join if you:
- Have an etonogestrel implant that was inserted 34–36 months ago (about 3 years ago)
- Are willing to continue to use the etonogestrel implant for an additional 24 months and do not intend to use any other form of contraception (for example, condoms)
- Are between 18 and 35 years old
There may be reasons why you cannot be in this clinical trial. The trial doctor or staff will discuss these with you.
If you join, you will:
- Be in the trial for about 27 months
- Visit the trial site 11 times for the trial doctor and staff to check on your health and collect information for research purposes
Being part of this clinical trial is voluntary and you may choose to leave the trial for any reason at any time.
For more information, including possible risks and benefits of participation, or if you want to take part in this clinical trial, please contact us today.
You will be compensated for your time and travel if you qualify
Who can be in this study?
- Boys and girls 9-11 years of age who have:
- No previous diagnosis of Covid-19
- Not yet received an HPV vaccine such as Gardasil 9
- Not yet received a COVID-19 vaccine
- A parent or legal guardian who:
- Will attend all study visits
- Agrees that the study doctor or staff may be in contact during the study
- Additional requirements apply, which the study doctor can discuss with you.
What vaccines will participants get as part of this study?
Everyone in this study will get:
A 2-dose regimen of the Moderna COVID-19 vaccine
A 2-dose regimen of the HPV vaccine Gardasil 9
You will be compensated for your time and travel if you qualify
About the LUMINOUS Study
This clinical research study is investigating whether an investigational contraceptive skin patch can prevent pregnancy in women, and how well tolerated it is.
This study is for you if you:
- are sexually active
- are at least 16 years of age (and legally permitted to use contraceptives)
- have normal, regular menstrual cycles
- wish to prevent and have no plans for pregnancy for at least 12 months
- are willing to try an investigational hormonal method of birth control
- are willing to use the study patch as your only method of birth control for at least 12 months.
If you have answered yes to all of the above then you may be able to take part in the LUMINOUS Study. There are other criteria that you will need to meet to qualify, which the study team can discuss with you.
All participants will receive the investigational contraceptive patch there is no 'dummy or placebo patch in this study.
You will be compensated for your time and travel if you qualify
What will this study involve?
This study is for you if you:
- are 35 years of age or younger at onset of study participation
- are having vaginal sexual intercourse with a male partner at least once a month
- do not wish to become pregnant within the next year
- have a history of regular menstrual cycles of 21 to 35 days prior to the use of any hormonal contraceptive.
These are some of the things you will need to do:
Daily diary entries
Take the investigational medication, once a day, by mouth.
If you take part, you will be in the OG-8175A-023 Study for up to 14 months.
You will be compensated for your time and travel if you qualify
CLINICAL TRIAL FOR ACTIVE UTI IN WEST PALM BEACH, FL
- Female participants only who are aged 18+ experiencing active UTI symptoms.
- Symptoms of a urinary tract infection include painful urination, frequent urination, urgency to urinate, and lower abdominal pain.
- No oral antibiotics or antifungal medications taken in the last week
Four study visits within a 30-day period.
You will be compensated for your time and travel if you qualify
COVID-19 RESEARCH STUDY IN WEST PALM BEACH, FL
Eligibility Criteria for COVID-19 Research Study
For this study, we are seeking individuals in and around West Palm Beach who are experiencing symptoms or have been exposed to COVID-19. As defined by the CDC, the most common out of a wide range of symptoms include:
- Fever or chills
- Cough
- Shortness of breath or difficulty breathing
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhea
In addition to being symptomatic, the only other criteria to participate in this research study is that you must be 18 or older and willing to have one or multiple nasal swabs.
If you qualify and choose to participate, you will be helping us get one step closer to achieving broader, faster COVID-19 testing that also more accurately identifies variant strains.
If you believe you are eligible for the COVID-19 research study at Comprehensive Clinical Research in West Palm Beach, FL, give us a call at 561-478-3177 today to answer our prescreening questions and get enrolled!
You will be compensated for your time and travel if you qualify
This study is for you if you:
A Female
Are between the ages 18-45 with regular menstrual cycles
No osteopenia or osteoporosis
These are some of the things you will need to do:
4 in-person visits over 12 months
You will be compensated for your time and travel if you qualify
A Phase IV, Longitudinal, Observational Study Examining
Real-World Outcomes of Non-Hormonal Pharmacotherapies
among Individuals Treated for Bothersome Vasomotor
What will this study involve?
Participants will be in the study for 2 years following the first visit. You will start a new course of treatment with a non-hormonal medication for the treatment of Hot Flashes. The study will assess the change in symptom bother from the first visit of participants initiating non hormonal medicine for the treatment of VMS in the real-world setting. The study will also assess impact on sleep characteristics/quality, treatment satisfaction, impact on quality of life (including mood and sexual health), work productivity.
This study is for you if you:
- You were assigned female at birth aged 40 through 75 years.
- You were diagnosed with bothersome VMS due to/associated with menopause for at least 3 months.
- You are utilizing complementary and alternative therapies, mind-body techniques, or supplements for the treatment of VMS: participant has been on such therapies for ≥ 3 months and intends to continue through duration of study.
These are some of the things you will need to do:
Diary Entries
Study Visits for 24 weeks
Take medication as instructed
You will be compensated for your time and travel if you qualify.
What will this study involve?
Participants will be in the study for 1 year following the first visit. You will start a new course of treatment with a non-hormonal medication for the treatment of Hot Flashes. The study will assess the change in symptom bother from the first visit of participants initiating non hormonal medicine for the treatment of VMS in the real-world setting. The study will also assess impact on sleep characteristics/quality, treatment satisfaction, impact on quality of life (including mood and sexual health), work productivity.
This study is for you if you:
- are Female 40-65 with vasomotor menopausal symptoms.
- FSAD was diagnosed by an expert and in accordance with DSM-IV-TR
- are Postmenopausal status or have had a hysterectomy greater then 6 months ago.
- have sexual activity at least two times each month during the last 6 months and agrees to have sexual activity at least two times each month for the duration of the study. Sexual activity can include any activity that may result in sexual stimulation or sexual pleasure e.g., intercourse, caressing, foreplay, masturbation, and oral sex.
These are some of the things you will need to do:
Daily diary entries.
Take the investigational medication.
If you take part, you will be in the Study for up to 4 months.
You will be compensated for your time and travel if you qualify.
A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density
with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis
What will this study involve?
The primary objective of this study is to characterize changes in bone mineral density.
This study is for you if you:
- Are a premenopausal woman, 18 to 50 years of age (inclusive).
- Has either of the following conditions:
a. A diagnosis of uterine fibroids confirmed by imaging or review of medical records and reports heavy menstrual bleeding negatively affecting quality of life. b. A diagnosis of endometriosis - If at risk of pregnancy is willing to avoid pregnancy for 4 years (the duration of the treatment period) using nonhormonal methods of contraception;
These are some of the things you will need to do:
Study Visits and phone calls
Take the investigational medication.
If you take part, you will be in the Study for up to 4 years.
You will be compensated for your time and travel if you qualify.
Past ResearchStudies
ADOLESCENT COVID-19 VACCINE RESEARCH TRIAL IN WEST PALM BEACH, FL
Comprehensive Clinical Research is seeking adolescents in the West Palm Beach area to participate in a research study for a COVID-19 vaccine. After testing tens of thousands of adults, vaccine development company Novavax is moving to Phase 3 of their research trial to evaluate the efficacy of their COVID-19 vaccine on adolescents. This vaccine has proven to be very effective at protecting against mild, moderate, and severe disease caused by the original virus strain, as well as multiple variants in adults. With your help, this protection can soon be extended to adolescents as well.
Compensated Adolescent Research Study for Novavax COVID-19 Vaccine in West Palm Beach
The Novavax COVID-19 vaccine uses a different technology than the other vaccines currently FDA-approved for emergency use in the U.S. Novavax has developed a protein subunit COVID-19 vaccine, which uses non-infectious, purified virus proteins to generate a strong immune response with few side effects. The advantage of this type of vaccine technology is that we have been using it to protect individuals of all ages against other viruses, such as hepatitis B and Ebola, for years.
Rest assured, the safety of all trial participants is of the utmost priority to the Comprehensive Clinical Research team.
Eligibility Criteria for Novavax Adolescent COVID-19 Vaccine Research Trial
To participate in the Novavax research study in West Palm Beach, individuals must be between the ages of 12-17. Qualifying adolescents cannot have been previously diagnosed with COVID-19, SARS, or any autoimmune disorder. They also cannot have received a COVID-19 vaccine, any vaccines within 4 days of beginning the trial, or any immunoglobulin, blood products, or immunosuppressant drugs within the preceding 90 days.
Signed consent from a parent or legal guardian is required, as well as the presence of the parent or guardian during participation. You must also provide proof of guardianship, such as a birth certificate or notarized letter of guardianship. If a caretaker other than a parent or guardian is bringing the adolescent to the study, they may do so with a notarized letter of consent from that adolescent’s parent or legal guardian. The parent or guardian’s phone number must be provided, as we will be in contact with them throughout the study. Emancipated adolescents who qualify may also participate.
The Novavax COVID-19 adolescent research study requires 8 visits to Comprehensive Clinical Research’s facility over the course of 2 years. If the adolescent qualifies and completes the study, compensation is made each visit up to $1600.
If you are eligible and interested, or have a child who is eligible and interested, in participating in our COVID-19 research trial in West Palm Beach, call 561-478-3177 today for more information about enrolling!
You will be compensated for your time and travel if you qualify
RESEARCH STUDY FOR FEMALES WITH CHLAMYDIA OR GONORRHEA IN WEST PALM BEACH, FL
Comprehensive Clinical Research is seeking qualifying women between the ages of 18 and older to participate in a research trial for chlamydia and gonorrhea prevention. This is a Phase 3 trial testing EVO100, a vaginal gel from Evofem Biosciences designed to balance normal acidic vaginal pH to prevent outbreaks of chlamydia and gonorrhea. The same technology has already been FDA approved as a form of birth control.
Our clinical research site is one of the most technologically advanced and accomplished in the country. You can rest assured that, in addition to providing quality data to help advance various medical solutions, your safety and wellbeing are our top priority.
Eligibility Criteria for EVO100 Clinical Research Trial in West Palm Beach
In order to participate in the Evofem research study, you must be a female between ages 18-24 who has been diagnosed with chlamydia or gonorrhea within the last 16 weeks by a doctor. Documentation of your diagnosis from a doctor is required. Alternatively, if you’re unable to get documentation, you can present a record of previous prescriptions for either STI, but you must also exhibit at least one of the following risk factors:
- New sex partner within last 12 weeks
- More than one current sex partner
- Knowledge that current sex partner has multiple partners
- Partner with a known STI
Inconsistent use of condoms among persons in a non-monogamous relationship
If you have been diagnosed with chlamydia or gonorrhea within the last 16 weeks but are unable to provide documentation of diagnosis or a previous prescription record, you may still participate in the study if you exhibit two or more of the above risk factors. Eligible females must also be using birth control (hysterectomy and condoms do not qualify), be sexually active with a male partner at least three times per month, and refrain from using any other vaginal products (douching, vaginal suppositories, spermicides, diaphragms, condoms) for the duration of the study. You also cannot be pregnant, breastfeeding, or planning to become pregnant within the next 6 months.
Qualifying participants will be required to make 7 visits to our research facility in West Palm Beach within 6 months. You will receive $25 at screening and up to $700 in total compensation if you complete the study.
If you qualify and wish to participate in the chlamydia and gonorrhea prevention research study at Comprehensive Clinical Research, contact us today to complete your prescreening and get enrolled!
You will be compensated for your time and travel if you qualify
*If you qualify, you will be compensated for your time and travel
